# Phase J.9.6 — Authorization Audit Retention, Access & Review Constraints (DESIGN-ONLY)

## 1. Purpose
- Define conceptual retention classes for authorization audit evidence.
- Establish immutability requirements for retained evidence.
- Define access roles and review boundaries in principle only.
- Mandate strict adherence to GDPR and clinical audit constraints.

## 2. Design-Only Confirmation
- This phase authorizes NO executable code.
- No infrastructure or storage systems.
- No vendors or cloud services.
- No IAM policies or identity systems.
- No encryption mechanisms.
- No operational procedures.
- No retention durations expressed in concrete values (days/years).

## 3. Conceptual Retention Classes
Authorize exactly three abstract retention classes:
- **Minimum Retention Class**: For standard operational verification and short-term forensic integrity.
- **Standard Regulatory Retention Class**: For compliance with healthcare and data protection regulations.
- **Extended Legal-Hold Retention Class**: For preservation during active investigation or legal requirements.

## 4. Immutability Guarantees
- Retained audit evidence MUST be append-only and tamper-evident.
- Retained evidence MUST be protected against deletion, mutation, or redaction throughout its retention lifecycle.
- Evidence MUST preserve its original state and sequence.

## 5. Access Roles in Principle
Access to audit evidence is restricted to the following conceptual roles only:
- **Auditor**: Authorized to review evidence for compliance and integrity verification.
- **Regulator**: Authorized to review evidence for legal or regulatory oversight.
- **System**: Authorized for automated lifecycle management and integrity checking.

## 6. Review and Disclosure Boundaries
- **Who may review**: Only authorized entities mapped to the conceptual roles above.
- **Formal Conditions**: Access must be granted only under documented formal conditions (e.g., active audit, court order, regulatory request).
- **Purpose Limitation**: Access is strictly limited to the stated purpose of the review; secondary use is strictly forbidden.

## 7. GDPR and Clinical Audit Constraints
- **Data Minimization**: Retention must be limited to the minimum necessary evidence to satisfy the purpose.
- **Purpose Limitation**: Evidence collected for audit purposes must not be repurposed.
- **Lawful Access**: Access must have a clear legal basis and be documented.
- **No Secondary Use**: Usage for analytics, training, or commercial purposes is strictly forbidden.

## 8. Fail-Closed Behavior
The system MUST mandate fail-closed behavior for:
- **Missing Audit Records**: Incomplete evidence sets must result in a failure state for the audit chain.
- **Incomplete Audit Chains**: Any break in the sequence of evidence must invalidate the chain.
- **Unauthorized Access Attempts**: Any attempt to access audit evidence outside of defined roles or conditions must be blocked and recorded.

## 9. Hard Prohibitions
- **NO DELETION**: Deletion of audit evidence prior to its lifecycle expiry is forbidden.
- **NO MUTATION**: Any modification of recorded evidence is strictly forbidden.
- **NO REDACTION**: Post-hoc redaction of audit evidence is forbidden.
- **NO SILENT ACCESS**: All access to audit evidence must be logged and visible to governance.
- **NO SELF-REVIEW**: Operational actors (e.g., developers, administrators) are strictly forbidden from reviewing their own audit trails.
- **NO AUTOMATED DECISION-MAKING**: Audit data must not be used as input for automated decision-making systems.

## 10. Phase Boundary
- J.9.6 defines retention and access constraints ONLY.
- J.9.7 is required for any concrete audit access implementation.
- No implementation may proceed under J.9.6.

## 11. Lock Statement
- Phase J.9.6 is DESIGN-ONLY.
- Phase J.9.6 is FINAL and IMMUTABLE unless amended by governance.
